Cash positive last quarter. Wow! Go Epichem, GO! I was not disappointed at all SW about the delaying of the Nasdaq listing, it makes perfect sense, now that they can do it. PAA will now be able to get in some decent phase 2 trial results up on the scoreboard, which, if it goes well, should mean much better ratings/sp and less dilution when it's time to raise more capital to advance the program. Is it any wonder people with the reputations of Locantro and Pisces are on board? Have a happy Easter everybody!
Ann: Appendix 4C - Quarterly Report & Company Update - March 2017, page-6
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.8¢ | 19.5¢ | $67.86K | 346.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 360690 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 792103 | 8 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |